Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein type (Monoclonal antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) –Global Forecast to 2020.

Dallas, TX -- (SBWire) -- 04/24/2015 --Rational protein design and untapped emerging markets are offering lucrative opportunities for growth in the Protein Engineering Market

Browse 100 market data tables and 53 figures spread through 180 pages and in-depth TOC on "Protein Engineering Market"

http://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html

Early buyers will receive 10% customization on this report.

The report segments the global protein engineering market on the basis of product, technology, protein type, end users, and geography. Based on type of product, the global protein engineering market is segmented into instruments, reagents, and services & software. Instrument is estimated to be the largest segment during the forecast period.

On the basis of technology, the market is divided into rational protein design and irrational protein design. Rational protein design is the largest as well as fastest growing segment of the protein engineering technology market. This growth is attributed to the need for better sensitivity, specificity, and faster technologies to engineer therapeutic proteins.

Inquiry before Buying:
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=898

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases. On the basis of end-users, this market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. Pharmaceutical & biotechnology companies are the major end users in the protein engineering end user market.

North America and Europe are established markets for protein engineering. However, developing regions such as the Middle East, Asia (China and India), and Pacific countries, are expected to witness a higher growth rate. Increased adoption of protein drugs which in turn resulted in increased intensity of research activities in the pharmaceutical sector is a major driver of these markets. To take advantage of the potential of developing economies and to gain the competitive edge, a number of companies are investing in these countries.

You can speak To Research Analyst to know more about Report:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=898

Key players operating in the protein engineering market are Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain
http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets